study 3, 32 patients（treated group）were scored using a questionnaire by nurses regarding the four symptoms （asthenia, muscular cramping, intradialysis hypotension, and dyspnea after exertion）before and after treatment with LC（at 12 and 24 weeks） , and the effects of LC on symptom scores were evaluated. Asthenia and muscular cramping exhibited noticeable changes after treatment（p＜0.001). Our studies revealed the beneficial effects of LC treatment on ESA-resistant anemia and dialysis-associated muscle symptoms, with no significant adverse events. 
連日経口投与した．投与方法は透析サイクルに応

